✦ LIBER ✦

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) Trial After Completion of 5 Years' Adjuvant Treatment for Breast Cancer

✍ Scribed by Cianfrocca, M.E.; Gradishar, W.J.

Book ID: 123263847
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 93 KB
Volume: 17
Category: Article
ISSN: 1043-321X
DOI: 10.1016/S1043-321X(06)80466-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of the ATAC (Arimidex, Tamoxifen

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 66 KB

P127 Efficacy data from the ATAC (“arimi

P127 Efficacy data from the ATAC (“arimidex”, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment

✍ Tony Howell 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 50 KB

P128 Safety and tolerability data from t

P128 Safety and tolerability data from the ATAC(‘arimidex’, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment

✍ Wolfgang Distler 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Quality of Life of Postmenopausal Women

Quality of Life of Postmenopausal Women in the ATAC (“Arimidex”, Tamoxifen, Alone or in Combination) Trial after Completion of 5

✍ David Cella; Lesley Fallowfield; Peter Barker; Jack Cuzick; Gershon Locker; Anth 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 205 KB

Anastrozole alone or in combination with

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer : Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses

✍ The ATAC (Arimidex; Tamoxifen Alone or in Combination) Trialists' Group 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

## Abstract ## BACKGROUND The first analysis of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial (median follow‐up, 33 months) demonstrated that in adjuvant endocrine therapy for postmenopausal patients with early‐stage breast cancer, anastrozole was superior to tamoxifen in terms of d

3–38 Quality of Life of Postmenopausal W

3–38 Quality of Life of Postmenopausal Women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial

✍ Vassilopoulou-Sellin, R. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 155 KB